B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

PSMA5

MOLECULAR TARGET

proteasome 20S subunit alpha 5

UniProt: P28066NCBI Gene: 56862 compounds

PSMA5 (proteasome 20S subunit alpha 5) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting PSMA5

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Bortezomib2.7114
2Reserpine1.614

About PSMA5 as a Drug Target

PSMA5 (proteasome 20S subunit alpha 5) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented PSMA5 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

PSMA5 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.